Physiotherapy in the Management of Hemophilia

Beeton, Karen; Tuffley, Jane

doi:10.1002/9780470987124.ch34

Cited by 1 publication

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This is an important question to answer, particularly in relation to treatment in developing countries with a limited supply of concentrate, but treaters in developed countries are reluctant to reduce dosage because an increased risk of breakthrough bleeding is unacceptable. Physiotherapy is an integral part of good haemophilia care (Beeton & Tuffley, 2005). Its purpose is to recover normal joint and muscle function after bleeds (Beeton et al , 1998), and to promote activity and behaviour that protect joints.…”

Section: Treatment Of Haemophiliamentioning

confidence: 99%

Optimal haemophilia care versus the reality

Bolton‐Maggs

2006

Br J Haematol

View full text Add to dashboard Cite

SummaryHaemophilia A and B are inherited bleeding disorders whose diagnosis and management is generally well established and best provided by specialists in a comprehensive care setting. Patients may be put at unnecessary risk if appropriate expertise is not sought for the management of accidents and surgery. The delivery of a high quality comprehensive service to patients with bleeding disorders depends upon defined standards and a network of haemophilia centres in the UK with similar models in other countries. In developing countries, despite a shortage or absence of treatment products, development of local expertise results in an improved outlook and reduction in mortality. Optimal care for severe haemophilia includes accurate diagnosis, early and adequate factor replacement for bleeding episodes and the provision of prophylaxis from an early age to prevent joint bleeding and the consequent arthropathy. Haemophilia treatment is expensive resulting in considerable inequity in provision of care across the world. Despite decades of experience, optimal treatment levels are not robustly defined. Transfusion-transmitted infections continue to have a significant impact on patient management. The development of inhibitory antibodies seriously complicates the management both in morbidity and cost. While gene therapy has not yet produced the hoped-for cure, new technologies will produce improved products.

show abstract

Section: Treatment Of Haemophiliamentioning

confidence: 99%

Optimal haemophilia care versus the reality

Bolton‐Maggs

2006

Br J Haematol

View full text Add to dashboard Cite

show abstract

Physiotherapy in the Management of Hemophilia

Cited by 1 publication

References 28 publications

Optimal haemophilia care versus the reality

Optimal haemophilia care versus the reality

Contact Info

Product

Resources

About